clinical trial · NCT07088991
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
AstraZeneca·—·recruiting·n = 200
Neurofibromatosis
brief summary
Clinical and Demographic Characteristics of Adult Patients with NEurofibromatosis in RUSsia (NEREUS)
started
Jun 6, 2025
primary completion
Mar 31, 2028
completion
Mar 31, 2028
last updated
Mar 31, 2026
detailed description
Open-label single-arm, non-interventional, multi-center, cohort study for evaluation of clinical and patient reported outcomes in routine care settings
official title
Clinical and Demographic Characteristics of Adult Patients With NEurofibromatosis in RUSsia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol